| Financial Year |
March 31 2023 |
| Monetary Funds |
412,357,283.92 |
| Held-for-trading Financial Assets |
154,179,780.82 |
| Notes Receivable |
-- |
| Accounts Receivable |
90,395,083.28 |
| Advances to Suppliers |
9,960,449.31 |
| Other Receivables |
16,490,098.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
294,600,117.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,455,759.27 |
| Other Current Assets |
3,345,394.72 |
| Total Current Assets |
988,783,967.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
252,942.74 |
| Investment Properties |
-- |
| Fixed Assetes |
146,532,824.83 |
| Under-construction Projects |
18,875,623.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,968,049.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,173,710.28 |
| Deferred Income Tax Assets |
13,479,697.03 |
| Other Non-Current Assets |
12,203,570.22 |
| Sub-Total of Non-Current Assets |
397,423,666.28 |
| Total Assets |
1,386,207,634.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
167,014,957.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,885,215.59 |
| Taxes Payable |
12,224,550.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,688,585.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,570,939.79 |
| Other Current Liabilities |
724,091.75 |
| Sub-Total of Current Liabilities |
252,895,347.54 |
| Long-term Loans |
6,391,949.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
333,964.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,230,059.68 |
| Total Liabilities |
261,125,407.22 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
606,585,632.77 |
| Surplus Reserve |
33,670,457.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
384,863,191.51 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,125,082,226.82 |
| Owner's Equity（Stockholder's Equity） |
1,125,082,226.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,386,207,634.04 |
